Endometrial Biopsy Cannulae Market - Size, Share, Outlook and Opportunity Analysis, 2018 – 2026

1. ENDOMETRIAL BIOPSY CANNULAE MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Endometrial Biopsy Cannulae - Overview Endometrial Biopsy Cannulae Market by Product Type (Rigid Endometrial Biopsy Cannulae and Flexible Endometrial Biopsy Cannulae), by End User (Hospitals, Diagnostic Centers, Specialty Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook and Opportunity Analysis, 2018 – 2026 An endometrial biopsy is a procedure used for obtaining small and thin section of endometrial tissue, which is the inner most lining of the uterus, for disease detection and testing. Clinically endometrial biopsy cannulae is used for the evaluation of infertility, amenorrhea, uterine cancer, abnormal uterine bleeding or endometrial infection. Endometrial biopsy cannulae are available in varying size. They are effective and affordable small medical devices used for regular diagnostic practice. Disease detection through biopsy is gaining significant demand owing to its accuracy, which is expected to drive growth of the endometrial biopsy cannulae market growth over the forecast period. For instance, according to the National Cancer Institute, around 85% of endometrial cancer are diagnosed at an earlier stage using endometrial sampling or biopsy. Moreover, increasing incidence of uterus related diseases is driving growth of the endometrial biopsy cannulae market. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing- insight/endometrial-biopsy-cannulae-market-1937 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Increasing incidence of uterine cancer is a major factor propelling demand for endometrial biopsy cannulae. For instance, according to the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program, an estimated 63,230 new cases of cancer were reported in 2018 in the U.S., which is around 26 cases per 100,000 women. The same source reported that an estimated 2.9% women are expected to have uterine cancer during their lifespan. Therefore, population at a risk of developing cancer frequently undergo cancer diagnosis, which is propelling demand for endometrial biopsy cannulae. According to American Cancer Society’s (ACS) publication, Cancer Facts & Figures 2018, around 92% of uterine cancer are observed in endometrial lining and high prevalence of obesity increases the risk of uterine cancer development proportionally. Infertility is also diagnosed using biopsy and high prevalence of infertility related issues are also expected to fuel growth of the endometrial biopsy cannulae market over the forecast period. For instance, according to Maternal Health Task Force (MHTF), a project of the Women and Health Initiative at the Harvard T.H. Chan School of Public Health, 2017, nearly 50 million couples across the world experience infertility. Request a Sample copy of this reports :https://www.coherentmarketinsights.com/insight/request-sample/1937 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Abnormal uterine bleeding is also a significant clinical condition which is driving demand for endometrial biopsy. According to Best Practice & Research. According to data published by Clinical Obstetrics & Gynaecology in 2016, heavy menstrual bleeding affects 14-25% of women in the reproductive age. Moreover, it states that 800,000 women consult medical professionals for abnormal uterine bleeding annually. Increasing initiatives to create awareness among population regarding early detection of diseases and the importance of reducing uterine cancer-related morbidity are major factors that are expected to boost growth of the endometrial biopsy cannulae market. For instance, governments and non-governmental organizations organize programs to spread awareness about early detection of cancer and its importance and also recommend periodic health check-ups. Endometritis, a uterine infection, is another common condition in low income economies, which require clinical attention. For instance, according to a study published in the Clinical and Experimental Reproductive Medicine journal in 2016, chronic endometritis affects around 10% of the global population. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1937 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved